Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins
about
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunitsDiversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.Machupo virus glycoprotein determinants for human transferrin receptor 1 binding and cell entry.Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses.Multifunctional nature of the arenavirus RING finger protein Z.Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteinsRole of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication.Early virus-host interactions dictate the course of a persistent infectionTransferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses.Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice.Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells.Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.Molecular basis of organ-specific selection of viral variants during chronic infectionNeutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein.Detection of virus-specific RNA-dependent RNA polymerase activity in extracts from cells infected with lymphocytic choriomeningitis virus: in vitro synthesis of full-length viral RNA species.Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity.Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus.Imported lassa fever in Germany: molecular characterization of a new lassa virus strainReplicon system for Lassa virus.siRNA screen for genes that affect Junín virus entry uncovers voltage-gated calcium channels as a therapeutic target.Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein.Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism.Characterization of temperature-sensitive mutants of Pichinde virus.Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation.Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes.
P2860
Q28602816-2A199CC1-90AE-4A30-B6EF-941F2CB9A036Q33933546-7505D5B1-4BD8-4EC8-BE56-78D4BF9B4F19Q33959298-0C541C63-CCC0-4DC7-AD95-F50462CD56D3Q34274569-9D99F2A3-5D6D-4856-9630-1E1FB6C2EB58Q34588241-EC57AAF3-8AB7-4DBC-ABE3-C7C2EB723E06Q34645925-4F8162C3-D387-45FF-BC98-C06E013A16C5Q34651454-18B15B88-5537-4EFB-9CC8-F3A4ED0F98EBQ34743550-2EA99EB1-0522-4254-A115-2B5A1A73E6F6Q34876341-87085E6F-64AD-4686-94AA-E1E062A70D15Q35399369-08599679-4669-4443-AF12-F143253235BEQ36230182-3E111BFC-2B16-49F2-BB6E-D07E3A6EF3E0Q36353608-FC3E2A13-1EA8-42CF-B1D5-97534D900C50Q36637294-BB6F63D9-6480-4410-8E2E-A7F33CA68B48Q36683932-048FE67C-8834-4402-9EEE-32C86B37DE4BQ36797304-BAA20727-C46E-4002-ABF0-477754AB32A8Q36800934-2E62E0AC-C665-49A1-8DA8-49C0EB20E318Q36827210-B7704A98-8FBF-487D-86C0-E8A6174C6206Q36831088-1F0FA4D5-4F40-4B04-9D03-56601294A72EQ36875351-7ADAB6A8-460F-40E0-8898-72BF3FBC59B2Q37064973-830BD513-5BAB-4954-ACBE-34244AA087B9Q39052889-B0B2F20D-0F64-4D9E-BC87-BC855546CA66Q39091684-C0B709E5-E9D1-4CD3-8412-87F080EA2E64Q39597992-3A2A10F9-09F4-4A1C-BF95-B0D285CD122BQ40094400-EF97F9C5-0F95-4C99-AB9A-EC4F47EBABF0Q40130829-626E88C9-C9E5-4E13-863E-38E0916203D3Q42066120-EC38B1E0-B42F-4C66-9D7A-04CB66322A54Q42939264-CA59A8DD-F310-4731-9AC7-D964417BB383Q42939799-00A43078-F8BA-4F36-AFAC-A05EB26B7775
P2860
Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins
description
1987 nî lūn-bûn
@nan
1987 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Site-specific antibodies defin ...... arenavirus GP-C glycoproteins
@ast
Site-specific antibodies defin ...... arenavirus GP-C glycoproteins
@en
Site-specific antibodies defin ...... arenavirus GP-C glycoproteins
@nl
type
label
Site-specific antibodies defin ...... arenavirus GP-C glycoproteins
@ast
Site-specific antibodies defin ...... arenavirus GP-C glycoproteins
@en
Site-specific antibodies defin ...... arenavirus GP-C glycoproteins
@nl
prefLabel
Site-specific antibodies defin ...... arenavirus GP-C glycoproteins
@ast
Site-specific antibodies defin ...... arenavirus GP-C glycoproteins
@en
Site-specific antibodies defin ...... arenavirus GP-C glycoproteins
@nl
P2093
P2860
P3181
P1433
P1476
Site-specific antibodies defin ...... arenavirus GP-C glycoproteins
@en
P2093
B S Parekh
M B Oldstone
M J Buchmeier
M K Wooddell
P J Southern
P2860
P3181
P577
1987-04-01T00:00:00Z